RALA and colorectal cancer: We used RALA specific target genes that were commonly deregulated in all three cell lines for analysis of their correlation with progression-free survival in five independent colorectal cancer datasets involving 1,227 colorectal cancer patients, for whom data on relapse-free survival were reported.